Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Identification and development of novel drug targets in stroke and other CNS injuries
| Reference number | 2009-00229 |
| Coordinator | Karolinska institutet - Institutionen för medicinsk biokemi och biofysik |
| Funding from Vinnova | SEK 25 000 000 |
| Project duration | July 2009 - November 2014 |
| Status | Completed |
